title: Inhibition of thrombin-induced platelet aggregation by high molecular weight kininogen.
abstract: 1. Thrombin-induced platelet aggregation and cleavage of [3H]FSBA-labeled aggregin is mediated by platelet calpain. 2. Plasma HMWK inhibits platelet aggregation and cleavage of aggregin in intact platelets, indirectly by thrombin and directly by calpain. 3. Inhibition of thrombin-induced platelet aggregation by HMWK is specific for this proteolytic enzyme. 4. HMWK is the major inhibitor of thrombin-induced activation of platelets in plasma.
authors.affiliation: Thrombosis Research Center, Temple University, Philadelphia, PA 19140.
authors.forename: R N
authors.initials: RN
authors.lastname: Puri
authors.forename: E J
authors.initials: EJ
authors.lastname: Gustafson
authors.forename: F X
authors.initials: FX
authors.lastname: Zhou
authors.forename: H
authors.initials: H
authors.lastname: Bradford
authors.forename: R F
authors.initials: RF
authors.lastname: Colman
authors.forename: R W
authors.initials: RW
authors.lastname: Colman
mesh_terms: D005340:Fibrinogen / Q000378:metabolism; D006801:Humans; D007610:Kallikreins / Q000378:metabolism; D007700:Kinetics; D007704:Kininogens / Q000502:physiology*; D008954:Models, Biological; D008970:Molecular Weight; D010974:Platelet Aggregation; D010980:Platelet Membrane Glycoproteins / Q000502:physiology; D013917:Thrombin / Q000502:physiology*
chemical_list: D007704:Kininogens; D010980:Platelet Membrane Glycoproteins; D005340:Fibrinogen; D007610:Kallikreins; D013917:Thrombin